This week The CRISPR Journal released the articles that people are talking about, and Asymmetrex’s article on p53 and CRISPR/Cas9 made the list. This article is free to read until February 7, 2019.
“I wish to suggest another explanation for the worrisome observations based on often overlooked properties of p53 as a regulator of postnatal tissue stem-cell kinetics. Unlike the DNA damage explanation, the second interpretation of the two reports also provides a simple solution for testing and application.”
The information provided by Asymmetrex (“we”, “us”, or “our”) on the Stem Cell Counting Center
Portal [https://asymmetrex.com/stem-cell-counting-center/] (the “Portal”) however accessed,
by internet browser or mobile application, is for general informational purposes only.
All information on the Portal is provided in good faith, however we make no representation or
warranty of any kind, express or implied, regarding the accuracy, adequacy, validity,
reliability, availability or completeness of any information provided to you by the Portal.
In specific, the Portal cannot and does not contain medical or health advice, or treatment
recommendations. The information is provided for general informational and educational purposes
only and is not a substitute for the advice of a qualified medical professional. Accordingly,
before taking any actions based upon information from the Portal, such as formulating dosage
levels and/or treatment plans, we encourage you to consult with a qualified medical professional
and/or specialist. UNDER NO CIRCUMSTANCE SHALL WE HAVE ANY LIABILITY TO YOU FOR ANY LOSS OR DAMAGE
OF ANY KIND INCURRED AS A RESULT OF THE USE OF THE PORTAL, OR RELAINCE ON ANY INFORMATION PROVIDED
BY THE PORTAL. YOU AGREE AND ARE AWARE YOUR USE OR RELIANCE OF ANY PORTAL INFORMATION IS SOLELY AT
YOUR OWN RISK.
Leave a Reply